430 related articles for article (PubMed ID: 12235527)
1. Successful treatment of pure red cell aplasia with a single dose of rituximab in a child after major ABO incompatible peripheral blood allogeneic stem cell transplantation for acquired aplastic anemia.
Maschan AA; Skorobogatova EV; Balashov DN; Pashanov ED; Trakhtman PE; Schipitzina IP; Skvortsova YV; Rumiantzev AG
Bone Marrow Transplant; 2002 Sep; 30(6):405-7. PubMed ID: 12235527
[TBL] [Abstract][Full Text] [Related]
2. Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies.
Helbig G; Stella-Holowiecka B; Wojnar J; Krawczyk M; Krzemien S; Wojciechowska-Sadus M; Markiewicz M; Wylezol I; Kopera M; Holowiecki J
Ann Hematol; 2007 Sep; 86(9):677-83. PubMed ID: 17486341
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of pure red cell aplasia with repeated, low doses of rituximab in two patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.
Helbig G; Stella-Holowiecka B; Krawczyk-Kulis M; Wojnar J; Markiewicz M; Wojciechowska-Sadus M; Kopera M; Kruzel T; Najda J; Nowak K; Holowiecki J
Haematologica; 2005 Nov; 90 Suppl():ECR33. PubMed ID: 16266924
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells for the treatment of refractory pure red cell aplasia after major ABO-incompatible hematopoietic stem cell transplantation.
Fang B; Song Y; Li N; Li J; Han Q; Zhao RC
Ann Hematol; 2009 Mar; 88(3):261-6. PubMed ID: 18769919
[TBL] [Abstract][Full Text] [Related]
5. Safety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch.
Scholl S; Klink A; Mügge LO; Schilling K; Höffken K; Sayer HG
Transfusion; 2005 Oct; 45(10):1676-83. PubMed ID: 16181220
[TBL] [Abstract][Full Text] [Related]
6. [Pure red cell aplasia after allogeneic transplantation of ABO incompatible hematopoietic stem cells].
Bullorsky E; Shanley C; Stemmelin G; Ceresetto J; Rabinovich O
Medicina (B Aires); 2002; 62(6):575-7. PubMed ID: 12532694
[TBL] [Abstract][Full Text] [Related]
7. Major ABO-incompatible hematopoietic stem cell transplantation: study of post-transplant pure red cell aplasia and endothelial cell chimerism.
Mueller RJ; Stussi G; Odermatt B; Halter J; Schanz U; Seebach JD
Xenotransplantation; 2006 Mar; 13(2):126-32. PubMed ID: 16623806
[TBL] [Abstract][Full Text] [Related]
8. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation.
Lee JH; Lee KH; Kim S; Lee JS; Kim SH; Kwon SW; Kim WK
Bone Marrow Transplant; 2000 Jan; 25(2):179-84. PubMed ID: 10673677
[TBL] [Abstract][Full Text] [Related]
9. Treatment of pure red cell aplasia after major ABO-incompatible peripheral blood stem cell transplantation by induction of chronic graft-versus-host disease.
Yamaguchi M; Sakai K; Murata R; Ueda M
Bone Marrow Transplant; 2002 Oct; 30(8):539-41. PubMed ID: 12379896
[TBL] [Abstract][Full Text] [Related]
10. [Pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation].
Huang XJ; Liu DH; Xu LP; Han W; Jiang Q; Chen YH; Zhang YC; Liu KY; Bao L; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2005 Sep; 26(9):548-50. PubMed ID: 16468333
[TBL] [Abstract][Full Text] [Related]
11. Resistant pure red cell aplasia after allogeneic stem cell transplantation with major ABO mismatch treated by escalating dose donor leukocyte infusion.
Verholen F; Stalder M; Helg C; Chalandon Y
Eur J Haematol; 2004 Dec; 73(6):441-6. PubMed ID: 15522068
[TBL] [Abstract][Full Text] [Related]
12. Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: removal of persisting isohemagglutinins with Ig-Therasorb immunoadsorption.
Rabitsch W; Knöbl P; Prinz E; Keil F; Greinix H; Kalhs P; Worel N; Jansen M; Hörl WH; Derfler K
Bone Marrow Transplant; 2003 Nov; 32(10):1015-9. PubMed ID: 14595389
[TBL] [Abstract][Full Text] [Related]
13. Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning.
Canals C; Muñiz-Díaz E; Martínez C; Martino R; Moreno I; Ramos A; Arilla M; Boto N; Pastoret C; Remacha A; Sierra J; Madoz P
Transfusion; 2004 Nov; 44(11):1603-11. PubMed ID: 15504166
[TBL] [Abstract][Full Text] [Related]
14. Prolonged isolated red blood cell transfusion requirement after allogeneic blood stem cell transplantation: identification of patients at risk.
Dahl D; Hahn A; Koenecke C; Heuft HG; Dammann E; Stadler M; Buchholz S; Krauter J; Eder M; Sykora KW; Klein C; Ganser A; Sauer M
Transfusion; 2010 Mar; 50(3):649-55. PubMed ID: 19929861
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation.
Zhu KE; Li JP; Zhang T; Zhong J; Chen J
Hematology; 2007 Apr; 12(2):117-21. PubMed ID: 17454192
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of acquired pure red cell aplasia (PRCA) by allogeneic peripheral blood stem cell transplantation.
Tseng SB; Lin SF; Chang CS; Liu TC; Hsiao HH; Liu YC; Tsai HJ; Chen TP
Am J Hematol; 2003 Dec; 74(4):273-5. PubMed ID: 14635209
[TBL] [Abstract][Full Text] [Related]
17. [ABO-incompatible allogeneic bone marrow transplantation].
Xu L; Guo N; Wang S
Zhonghua Xue Ye Xue Za Zhi; 1999 Aug; 20(8):413-5. PubMed ID: 11721421
[TBL] [Abstract][Full Text] [Related]
18. [Treatment with bolus methylprednisolone for pure red cell aplasia after ABO incompatible bone marrow transplantation in a patient with chronic myelocytic leukemia].
Furuya H; Wakayama T; Tanaka J; Tsumori M; Hatazoe T; Ohguni S; Sato T; Ishikura H; Kato Y
Rinsho Ketsueki; 1995 Nov; 36(11):1279-83. PubMed ID: 8691568
[TBL] [Abstract][Full Text] [Related]
19. [ABO incompatibility and non myeloablative allogeneic stem cell transplantation].
Malfuson JV; Hicheri Y; Bonin P; Rodet M; Boccaccio C; Pautas C; Kuentz M; Cordonnier C; Noizat-Pirenne F; Maury S
Transfus Clin Biol; 2007 Aug; 14(3):327-33. PubMed ID: 17462938
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of pure red cell aplasia after major ABO-incompatible T cell-depleted bone marrow transplantation with erythropoietin.
Santamaría A; Sureda A; Martino R; Domingo-Albós A; Muñiz-Díaz E; Brunet S
Bone Marrow Transplant; 1997 Dec; 20(12):1105-7. PubMed ID: 9466287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
